PRPO 5.27 (-1.5%)
US74019L5030Medical Diagnostics & ResearchDiagnostics & Research

Precipio (PRPO) Stock Highlights

5.27 | -1.5%
2024-12-21 07:41:53
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provide new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Statistics

Range Today
5.22 5.46
Volume Today 2.6K
Range 1 Year
4.31 7.3
Volume 1 Year 1.75M
Range 3 Year
4.31 38
Volume 3 Year 5.87M
Range 10 Year
4.31 8448
Volume 10 Year 85.66M

Highlights

Market Capitalization 7.81M (micro)
Floating Shares 1.31M
Current Price 5.27
Price To Earnings -3.02
Price To Revenue 0.54
Price To Book 0.52
Earnings Per Share -1.81
Payout Ratio 0%

Performance

Latest -1.5%
1 Month -12.17%
3 Months -20.75%
6 Months -0.57%
1 Year -21.34%
3 Years -84.03%
5 Years -88.08%
10 Years -99.8%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.